Báo cáo tài chính chính của Shanghai Bio-heart Biological Technology Co., Ltd. là gì?
Tỷ lệ tài chính chính của 02185.HK là gì?
Doanh thu của Shanghai Bio-heart Biological Technology Co., Ltd. được phân bổ theo phân khúc hoặc khu vực địa lý như thế nào?
Shanghai Bio-heart Biological Technology Co., Ltd. có lợi nhuận không?
Shanghai Bio-heart Biological Technology Co., Ltd. có nợ không?
Shanghai Bio-heart Biological Technology Co., Ltd. có bao nhiêu cổ phiếu đang lưu hành?
Thống kê chính
Giá đóng cửa trước
$5.62
Giá mở cửa
$5.62
Phạm vi ngày
$5.43 - $5.62
Phạm vi 52 tuần
$1.6 - $10.77
Khối lượng
39.6K
Khối lượng trung bình
344.9K
EPS (TTM)
-0.41
Tỷ suất cổ tức
--
Vốn hóa thị trường
$1.2B
BIOHEART-B là gì?
Shanghai Bio-Heart Biological Technology Co., Ltd. engages in the research and development of interventional cardiovascular device therapies. The company is headquartered in Shanghai, Shanghai and currently employs 70 full-time employees. The company went IPO on 2021-12-23. The firm's main businesses are the development and production of interventional cardiovascular devices. The firm's main products comprise fully bioresorbable scaffolds (BRS) and renal denervation (RDN). The firm's products are mainly used to meet medical needs for the treatment of coronary, peripheral artery disease and hypertension. The firm's products are used in addressing the unmet medical needs of Chinese patients for the treatment of coronary artery diseases and the unmet medical needs of patients for the treatment of uncontrolled hypertension. The firm mainly conducts its businesses in the domestic market and overseas markets.